MA51276A - Traitement de la fibrose avec de l'inositol - Google Patents

Traitement de la fibrose avec de l'inositol

Info

Publication number
MA51276A
MA51276A MA051276A MA51276A MA51276A MA 51276 A MA51276 A MA 51276A MA 051276 A MA051276 A MA 051276A MA 51276 A MA51276 A MA 51276A MA 51276 A MA51276 A MA 51276A
Authority
MA
Morocco
Prior art keywords
inositol
fibrosis
treatment
Prior art date
Application number
MA051276A
Other languages
English (en)
Inventor
Vittorio Unfer
Original Assignee
Lo Li Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lo Li Pharma Srl filed Critical Lo Li Pharma Srl
Publication of MA51276A publication Critical patent/MA51276A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
MA051276A 2017-12-22 2018-12-20 Traitement de la fibrose avec de l'inositol MA51276A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT201700148902 2017-12-22

Publications (1)

Publication Number Publication Date
MA51276A true MA51276A (fr) 2021-04-21

Family

ID=61731767

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051276A MA51276A (fr) 2017-12-22 2018-12-20 Traitement de la fibrose avec de l'inositol

Country Status (7)

Country Link
US (1) US20200390723A1 (fr)
EP (1) EP3727359B1 (fr)
BR (1) BR112020012687A2 (fr)
CA (1) CA3085612A1 (fr)
MA (1) MA51276A (fr)
MX (1) MX2020006451A (fr)
WO (1) WO2019122119A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245755B1 (en) * 1992-04-21 2001-06-12 Curators Of The Unversity Of Missouri Use of aldosterone antagonists to inhibit myocardial fibrosis
AU6876498A (en) 1997-04-03 1998-10-22 Point Biomedical Corporation Intravesical drug delivery system
MX2012000383A (es) * 2009-07-07 2012-06-01 Normoxys Inc Método para reducir la resistencia a terapias multidroga utilizando tripirofosfato de inositol.
ITUA20163025A1 (it) * 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico

Also Published As

Publication number Publication date
EP3727359A1 (fr) 2020-10-28
CA3085612A1 (fr) 2019-06-27
MX2020006451A (es) 2020-11-06
EP3727359B1 (fr) 2024-04-17
BR112020012687A2 (pt) 2020-11-24
WO2019122119A1 (fr) 2019-06-27
US20200390723A1 (en) 2020-12-17

Similar Documents

Publication Publication Date Title
MA45192A (fr) Traitement d'association
MA49631A (fr) Méthodes de traitement de la fibrose kystique
MA45481A (fr) Utilisation d'exosomes pour le traitement de maladies
MA54105A (fr) Méthodes de traitement de la fibrose kystique
MA39748A (fr) Cenicriviroc pour le traitement de la fibrose
MA41841A (fr) Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MA46180A (fr) Analogues de l'amyline
IL265528A (en) aav therapy for Huntington's disease
MA46788A (fr) Traitement de la fibrose
MA47719A (fr) Esketamine pour le traitement de la dépression
DK3635101T3 (da) Manipulerede ligasevarianter
MA43106A (fr) Traitement de l'oligo-ovulation associée à la stéatose hepatique
MA47820A (fr) Traitement de la glycogénose de type iii
IT201700100643A1 (it) Struttura di casseratura per l'esecuzione di getti per la realizzazione di solai
MA46099A (fr) Composés pour le traitement de maladies associées à un dysfonctionnement mitochondrial
MA41120A (fr) Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci
ITUA20161964A1 (it) Struttura di casseratura per l'esecuzione di getti orizzontali per la realizzazione di solai
FR3036971B1 (fr) Appareil de ventilation artificielle avec monitorage d'une absence de contractions thoraciques
MA52738A (fr) Méthodes de traitement de l'arthrite psoriasique
MA43764A (fr) Inhibiteur monovalent de l'interaction hutnfr1
MA51276A (fr) Traitement de la fibrose avec de l'inositol
FR3031112B1 (fr) Construction d'adn pour le traitement de pathologies oculaires
MA50995A (fr) Traitement du vrs avec une association médicamenteuse
MA42108A (fr) Traitement d'étoffes et textiles
FI20155818A (fi) Järjestely työkoneen nivelliitoksessa